Both in Biotechnology
Maze Therapeutics vs Replimune Group
Over the past year MAZE returned +3.0% and REPL returned +130.7%; their daily moves had a correlation of 0.07.
MAZE +3.0% REPL +130.7%Growth of $1, one year, split-adjusted
| Metric | MAZE | REPL |
|---|---|---|
| Price | $33.38 | $20.69 |
| Market cap | $1.85B | $1.96B |
| Today | +3.50% | +0.19% |
| 1 month | +26.3% | +56.2% |
| 6 months | +26.1% | +501.5% |
| Year to date | −19.4% | +112.9% |
| 1 year | +0.4% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 92.7× | — |
| Net cash | $372.1M | $183.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 77.7% |
| Short % of float | 18.8% | 29.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).